Intuitive Surgical tops quarterly estimates on strong demand for robotic systems

• Da Vinci procedure volume grew 15% globally year-over-year in Q2, with Q2 revenue of $2.89 billion beating analyst estimates of $2.82 billion
• Adjusted earnings reached $2.8 per share as the company raised its 2026 adjusted gross profit margin forecast to 68-69% from the previous 67.5-68.5% range
• Strong results contrast with HCA Healthcare's report of softer surgical demand and rising uninsured patients following expiration of pandemic-era Affordable Care Act subsidies

Summary

Intuitive Surgical exceeded Q2 expectations, reporting revenue of $2.89 billion versus analyst estimates of $2.82 billion, driven by strong demand for its da Vinci robotic surgical systems. The company posted adjusted earnings of $2.8 per share.

Key Performance Metrics:

• Global da Vinci procedure volume increased 15% year-over-year in Q2
• The company maintained its 2026 worldwide procedure growth forecast at 13.5% to 15.5%, expecting results near the midpoint
• Raised 2026 adjusted gross profit margin guidance to 68-69% of revenue, up from the previous forecast of 67.5-68.5%

Market Context:

Intuitive remains the dominant player in the surgical robotics market, benefiting from hospitals addressing procedure backlogs and expanding minimally invasive care access. The strong results contrast notably with Tuesday's report from HCA Healthcare, which indicated softer surgical demand and rising uninsured patient numbers following the expiration of pandemic-era Affordable Care Act subsidies.

Implications:

The divergence between Intuitive's robust performance and HCA's weaker trends suggests the robotic surgery segment is proving resilient despite broader healthcare demand concerns. Intuitive's ability to maintain growth forecasts and raise margin expectations indicates continued market share expansion and operational efficiency improvements. The company's consistent demand signals hospitals' ongoing investment in advanced surgical technology despite potential headwinds in the broader healthcare sector.

The results reinforce Intuitive's competitive moat in surgical robotics and suggest the company is well-positioned to capitalize on long-term trends toward automated, minimally invasive procedures.